The craze for Trump's chloroquine COVID-19 remedy is dying out
You may have noticed that mentions of antimalarial drugs as remedies for the novel coronavirus infection have fallen off a cliff lately. Two new data points released in recent days might well end the craze completely.
The two latest developments include a study of cases at Veterans Affairs Department hospitals showing that COVID-19 patients who received hydroxychloroquine died at higher rates than those who didnt receive it.
Nor did the researchers find that treatment with the drug affected the rate at which the patients, who generally had advanced COVID-19 illness, needed to be put on ventilators, the most extreme therapy for the disease.
The second development is an advisory from the National Institutes of Health recommending against the use of hydroxychloroquine in conjunction with the antibiotic azithromycin in COVID-19 cases. The advisory carries the code A-III, meaning that its a strong recommendation against, based on expert opinion. The NIH cites the drug combinations potential for toxicities.
https://www.latimes.com/business/story/2020-04-22/trump-chloroquine-craze